Advancing diagnostic precision, integrated therapies, evidence generation, and equitable access are key opportunities to enhance skeletal dysplasia management across global healthcare settings.

Bone tumours represent a diverse group of neoplasms that pose significant diagnostic and therapeutic challenges. Adamantinoma—a rare, low-grade malignant tumour—typically arises in the tibia and is ...

In the physiological condition of skeletogenesis (left), SSCs maintain a quiescent state for orderly differentiation which is regulated by the epigenetic signature. Especially at this state, ...

A clinical trial at the National Institutes of Health found that a medication, denosumab, significantly reduced abnormal bone turnover in adults with fibrous dysplasia, a rare disease marked by weak ...